Experience of polymyositis and antisynthetase syndrome treatment with rituximab

The patient with polymyositis and antisynthetase syndrome treated with rituximab (Mabtera) is described. Rituximab was added to thehigh‑dose cyclophosphamide therapy due to an acute onset of the disease with a highly progressive interstitial lung disease and inability of the high‑dose corticosteroid...

Full description

Saved in:
Bibliographic Details
Main Authors: S. G. Palshina, S. S. Nikitin, V. I. Vasilyev
Format: Article
Language:Russian
Published: ABV-press 2015-02-01
Series:Нервно-мышечные болезни
Subjects:
Online Access:https://nmb.abvpress.ru/jour/article/view/88
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849240939744198656
author S. G. Palshina
S. S. Nikitin
V. I. Vasilyev
author_facet S. G. Palshina
S. S. Nikitin
V. I. Vasilyev
author_sort S. G. Palshina
collection DOAJ
description The patient with polymyositis and antisynthetase syndrome treated with rituximab (Mabtera) is described. Rituximab was added to thehigh‑dose cyclophosphamide therapy due to an acute onset of the disease with a highly progressive interstitial lung disease and inability of the high‑dose corticosteroids therapy because of comorbidity. There was almost complete normalization of pulmonary and muscular pathological changes with more than 4‑fold decrease of anti‑Jo‑1 antibodies on the treatment. No complications and no side effects during rituximab therapy were noted. This case report demonstrates the positive effect of rituximab in combination with high‑dose cyclophosphamide in the treatment of acute AS syndrome. The results published in literature are discussed.
format Article
id doaj-art-3ebfd42a292240f2bd500f5609cd708c
institution Kabale University
issn 2222-8721
2413-0443
language Russian
publishDate 2015-02-01
publisher ABV-press
record_format Article
series Нервно-мышечные болезни
spelling doaj-art-3ebfd42a292240f2bd500f5609cd708c2025-08-20T04:00:20ZrusABV-pressНервно-мышечные болезни2222-87212413-04432015-02-0103455410.17650/2222-8721-2012-0-3-45-5482Experience of polymyositis and antisynthetase syndrome treatment with rituximabS. G. Palshina0S. S. Nikitin1V. I. Vasilyev2Research Institute of Rheumatology of Russian Academy of Medical SciencesThe Institute of General Pathology and Pathophysiology of Russian Academy of Medical Sciences, MoscowResearch Institute of Rheumatology of Russian Academy of Medical SciencesThe patient with polymyositis and antisynthetase syndrome treated with rituximab (Mabtera) is described. Rituximab was added to thehigh‑dose cyclophosphamide therapy due to an acute onset of the disease with a highly progressive interstitial lung disease and inability of the high‑dose corticosteroids therapy because of comorbidity. There was almost complete normalization of pulmonary and muscular pathological changes with more than 4‑fold decrease of anti‑Jo‑1 antibodies on the treatment. No complications and no side effects during rituximab therapy were noted. This case report demonstrates the positive effect of rituximab in combination with high‑dose cyclophosphamide in the treatment of acute AS syndrome. The results published in literature are discussed.https://nmb.abvpress.ru/jour/article/view/88antisynthetase syndromeidiopathic inflammatory myopathypolymyositisdermatomyositisrituximab
spellingShingle S. G. Palshina
S. S. Nikitin
V. I. Vasilyev
Experience of polymyositis and antisynthetase syndrome treatment with rituximab
Нервно-мышечные болезни
antisynthetase syndrome
idiopathic inflammatory myopathy
polymyositis
dermatomyositis
rituximab
title Experience of polymyositis and antisynthetase syndrome treatment with rituximab
title_full Experience of polymyositis and antisynthetase syndrome treatment with rituximab
title_fullStr Experience of polymyositis and antisynthetase syndrome treatment with rituximab
title_full_unstemmed Experience of polymyositis and antisynthetase syndrome treatment with rituximab
title_short Experience of polymyositis and antisynthetase syndrome treatment with rituximab
title_sort experience of polymyositis and antisynthetase syndrome treatment with rituximab
topic antisynthetase syndrome
idiopathic inflammatory myopathy
polymyositis
dermatomyositis
rituximab
url https://nmb.abvpress.ru/jour/article/view/88
work_keys_str_mv AT sgpalshina experienceofpolymyositisandantisynthetasesyndrometreatmentwithrituximab
AT ssnikitin experienceofpolymyositisandantisynthetasesyndrometreatmentwithrituximab
AT vivasilyev experienceofpolymyositisandantisynthetasesyndrometreatmentwithrituximab